Patient-derived Parathyroid Organoids As a Tracer and Drug-screening Application Model
Overview
Authors
Affiliations
Parathyroid diseases are characterized by dysregulation of calcium homeostasis and alterations in parathyroid hormone (PTH) excretion. The development of parathyroid-targeted treatment and imaging tracers could benefit from in vitro models. Therefore, we aim to establish a patient-derived parathyroid organoid model representing human parathyroid tissue. Hyperplastic parathyroid tissue was dispersed, and parathyroid organoids (PTOs) were cultured and characterized. PTO-derived cells exhibited self-renewal over several passages, indicative of the presence of putative stem cells. Immunofluorescence and RNA sequencing confirmed that PTOs phenocopy hyperplastic parathyroid tissue. Exposure of PTOs to increasing calcium concentrations and PTH-lowering drugs resulted in significantly reduced PTH excretion. PTOs showed specific binding of the imaging tracers C-methionine and Tc-sestamibi. These data show the functionality of PTOs resembling the parathyroid. This PTO model recapitulates the originating tissue on gene and protein expression and functionality, paving the way for future physiology studies and therapeutic target and tracer discovery.
Spatially defined microenvironment for engineering organoids.
Zhang Y, Qi F, Chen P, Liu B, Li Y Biophys Rev (Melville). 2024; 5(4):041302.
PMID: 39679203 PMC: 11646138. DOI: 10.1063/5.0198848.
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.
Taurin S, Alzahrani R, AlOraibi S, Ashi L, Alharmi R, Hassani N Transl Oncol. 2024; 51:102226.
PMID: 39622151 PMC: 11647637. DOI: 10.1016/j.tranon.2024.102226.
Challenges in molecular diagnosis of multiple endocrine neoplasia.
Romanet P, Charnay T, Sahakian N, Cuny T, Castinetti F, Barlier A Front Endocrinol (Lausanne). 2024; 15:1445633.
PMID: 39398337 PMC: 11466760. DOI: 10.3389/fendo.2024.1445633.
Senkal-Turhan S, Bulut-Okumus E, Aydin M, Turkmen N, Taslidere A, Sahin F Adv Sci (Weinh). 2024; 11(43):e2407567.
PMID: 39331961 PMC: 11578294. DOI: 10.1002/advs.202407567.
Wang G, Du Y, Cui X, Xu T, Li H, Dong M Cell Prolif. 2024; 57(8):e13634.
PMID: 38494923 PMC: 11294423. DOI: 10.1111/cpr.13634.